Correlation between mast cell density and histological parameters in Helicobacter pylori-associated gastritis

1. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004; 9:453-9.10.1111/j.1083-4389.2004.00260.x15361085Open DOISearch in Google Scholar

2. Zheng PY, Hua J, Yeoh KG, Ho B. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000; 47:18-22.10.1136/gut.47.1.18172797710861258Open DOISearch in Google Scholar

3. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20:1161-81.10.1097/00000478-199610000-000018827022Open DOISearch in Google Scholar

4. McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000; 16: 24-31.10.1097/00001574-200001000-0000517024012Open DOISearch in Google Scholar

5. Basso D, Navaglia F, Brigato L, Di Mario F, Rugge M, Plebani M. Helicobacter pylori non-cytotoxic genotype enhances mucosal gastrin and mast cell tryptase. J Clin Pathol. 1999; 52:210-4.10.1136/jcp.52.3.21050108110450181Open DOISearch in Google Scholar

6. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol. 2003; 70:5590-6.10.4049/jimmunol.170.11.559012759438Open DOISearch in Google Scholar

7. Mysorekar VV, Dandekar CP, Prakash BS. Mast cells in Helicobacter pylori associated antral gastritis. Indian J Pathol Microbiol. 2003; 46:605-9.Search in Google Scholar

8. Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther. 2004; 20 Suppl 1: 165-70.10.1111/j.1365-2036.2004.01974.x15298623Open DOISearch in Google Scholar

9. Kayaselcuk F, Serin E, Gumurdulu Y, Bircan S, Tuncer I. Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus. Turk J Gastroenterol. 2002; 13:154-8.Search in Google Scholar

10. Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN. Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol. 2002; 55:133-7.10.1136/jcp.55.2.133176958611865009Open DOISearch in Google Scholar

11. Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L. Prevalence of CagA and VacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004; 87:1327-31.Search in Google Scholar

12. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion. 2006; 73:116-23.10.1159/00009404316788292Search in Google Scholar

13. Matsuhisa TM, Yamada NY, Kato SK, Matsukura NM. Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects. Helicobacter. 2003; 8: 29-35.10.1046/j.1523-5378.2003.00121.x12603614Open DOISearch in Google Scholar

14. Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N, et al. Mast cell chymase expression in Helicobacter pylori-associated gastritis. Histopathology. 2003; 43:538-49.10.1111/j.1365-2559.2003.01731.xOpen DOISearch in Google Scholar

15. Saperas E. The role of mast cells in gastrointestinal inflammation. Gastroenterology. 1996; 110:1656-8.10.1053/gast.1996.v110.agast961656Open DOISearch in Google Scholar

16. Bodger K, Bromelow K, Wyatt JI, Heatley RV. Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion. J Clin Pathol. 2001; 54:285-92.10.1136/jcp.54.4.285Open DOISearch in Google Scholar

17. Kempuraj D, Huang M, Kandere-Grzybowska K, Basu S, Boucher W, Letourneau R, et al. Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NFkappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol. 2003; 132:231-9.10.1159/000074304Search in Google Scholar

18. Theoharides TC, Bielory L. Mast cells and mast cell mediators as targets of dietary supplements. Ann Allergy Asthma Immunol. 2004; 93:S24-34.10.1016/S1081-1206(10)61484-6Open DOISearch in Google Scholar

19. Temkin V, Kantor B, Weg V, Hartman ML, Levi-Schaffer F. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol. 2002; 169:2662-9.10.4049/jimmunol.169.5.266212193739Search in Google Scholar

20. Sasaki Y, Yoshimoto T, Maruyama H, Tegoshi T, Ohta N, Arizono N, Nakanishi K. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med. 2005; 202:607-16.10.1084/jem.20042202221286216129701Search in Google Scholar

21. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer. World J Gastroenterol. 2006; 12:6869-73.10.3748/wjg.v12.i42.6869408744517106939Open DOISearch in Google Scholar

22. Liu Y, Ponsioen CI, Xiao SD, Tytgat GN, Ten Kate FJ. Geographic pathology of Helicobacter pylori gastritis. Helicobacter. 2005; 10:107-13.10.1111/j.1523-5378.2005.00304.x15810940Open DOISearch in Google Scholar

23. Lin HJ, Perng CL, Lo WC, Wu CW, Tseng GY, Li AF, et al. Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan. World J Gastroenterol. 2004; 10:2493-7. 10.3748/wjg.v10.i17.2493457214815300891Open DOISearch in Google Scholar